课题基金 / 基金详情

Inflammation Biomarkers for Diagnosis and Prognosis of Early Stage Lung Cancer

Inflammation Biomarkers for Diagnosis and Prognosis of Early Stage Lung Cancer
用于早期肺癌诊断和预后的炎症生物标志物
批准号:
8938193
负责人:
Brid Ryan
金额:
$8.24万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Brid Ryan的其他基金

相似基金

相关文献

中文摘要
翻译
在我们之前的研究基础上,我们发现肺癌诊断患者中循环细胞因子增加,我们正在检查国家肺筛查试验的血浆样本,以寻找细胞因子诊断和预后的标志。这项研究扩展了以往的研究:a)这是一项前瞻性研究,b)良性和恶性病变都是通过低剂量螺旋CT发现的。我们还在检查手术后细胞因子的信号是否下降,并跟踪肿瘤复发,作为一项初步研究,以质疑细胞因子是否可以用来模拟肿瘤复发。这项研究目前正在进行中。
英文摘要
Building on our previous studies where we found increased circling cytokines among patients with a lung cancer diagnosis, we are examining plasma samples from the National Lung Screening Trial for a cytokine diagnostic and prognostic signature. This study extends previous studies as a) this is a prospective study and b) the lesions both benign and malignant, were detected b low dose helical CT. We are also examining whether the signal from cytokines declines following surgery and tracks with tumor recurrence, as a preliminary study to query whether cytokines could be used to model tumor recurrence. This study is currently ongoing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lung Cancer Health Disparities
Causes and Consequences of Lung Cancer Health Disparities
Gene-Environment Interactions in Lung Cancer
Lung Cancer Health Disparities
海外基金